Fraisinib: a calixpyrrole derivative reducing A549 cells-derived NSCLC tumor in-vivo, acts as ligand of the Glycine-tRNA Synthase, a new molecular target in oncology User montaukwhaler, in the non small cell lung cancer subreddit, 29 Nov 2023